Basil Drugs And Pharmaceuticals Private Limited, a active private limited company, was established on 24 January 2018 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24303MH2018PTC304632. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.50 M and a paid-up capital of ₹5.50 M.
Employing 20 professional, Its leadership includes Priyamvada Anup Singh (Director), Anup Dinesh Singh (Director), Punit Girdhar Kasat (Additional Director). Past directors included Mudrika Shivshankar Banger, Shivshankar Gangaram Bangar, Nipaben Bhadreshbhai Shah. It holds ₹10.28 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A 609 Sagar Tech Plaza Andheri Kurla Rd Sakinaka Junction Andheri (E), Mumbai, Maharashtra, 400072.
U24303MH2018PTC304632
304632
24 January 2018
₹5.50 M
₹5.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Basil Drugs And Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Priyamvada Anup Singh | Director | 24 Jan 2018 | Current |
| Anup Dinesh Singh | Director | 24 Jan 2018 | Current |
| Punit Girdhar Kasat | Additional Director | 10 Jun 2025 | Current |
| Finil Bharat Pandya | Additional Director | 10 Jun 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Jul 2023 | Past |
| Pramod Abcsdd | Director | 10 Jul 2023 | Past |
| Pramod Abcsdd | Additional Director | 17 Feb 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Basil Drugs And Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 31.56% decrease. The company also saw a substantial fall in profitability, with a 53.28% decrease in profit. The company's net worth Soared by an impressive increase of 387.8%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Basil Drugs And Pharmaceuticals had a public holding of 22.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹102,830,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Jun 2025 | Canara Bank | ₹5.00 Cr | Open |
| 27 Mar 2024 | State Bank Of India | ₹4.99 Cr | Open |
| 20 May 2022 | Hdfc Bank Limited | ₹0.49 M | Open |
| 20 May 2022 | Hdfc Bank Limited | ₹0.98 M | Open |
| 12 May 2022 | Hdfc Bank Limited | ₹0.49 M | Open |
Explore comprehensive loan charge details -
Basil Drugs And Pharmaceuticals has a workforce of 20 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Basil Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Basil Drugs And Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Canara Bank amounted to Rs. 50.00 M with Charge ID 101119968 was registered on 17 Jun 2025. was completed.
Punit Girdhar Kasat was appointed as a Additional Director was appointed as a Additional Director on 10 Jun 2025 & has been associated with this company since 6 months 8 days . was recorded as a recent event.
The activity Finil Bharat Pandya was appointed as a Additional Director was appointed as a Additional Director on 10 Jun 2025 & has been associated with this company since 6 months 8 days . was completed.
Basil Drugs And Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Basil Drugs And Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
A charge with State Bank Of India amounted to Rs. 49.90 M with Charge ID 100895209 was registered on 27 Mar 2024. was recorded as a recent event.
The CIN of Basil Drugs And Pharmaceuticals Private Limited is U24303MH2018PTC304632.
Basil Drugs And Pharmaceuticals Private Limited is headquartered at A 609 Sagar Tech Plaza Andheri Kurla Rd Sakinaka Junction Andheri (E), Mumbai, Maharashtra, 400072.
Basil Drugs And Pharmaceuticals Private Limited was incorporated on 24 January 2018.
The current directors of Basil Drugs And Pharmaceuticals Private Limited are
The primary industry of Basil Drugs And Pharmaceuticals Private Limited is Manufacturing.
Basil Drugs And Pharmaceuticals Private Limited is unlisted.
The authorized capital of Basil Drugs And Pharmaceuticals Private Limited is ₹5.50 M, and the paid-up capital is ₹5.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX